Anzeige
Mehr »
Mittwoch, 10.09.2025 - Börsentäglich über 12.000 News
BREAKING NEWS: CiTech unterzeichnet Exklusivvertrag mit Babcock - Ukraine-Deal katapultiert Aktie in neue Liga
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 755122 | ISIN: IS0000000040 | Ticker-Symbol: 5IQ
Frankfurt
10.09.25 | 15:01
4,220 Euro
+2,43 % +0,100
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
EMBLA MEDICAL HF Chart 1 Jahr
5-Tage-Chart
EMBLA MEDICAL HF 5-Tage-Chart
PR Newswire
332 Leser
Artikel bewerten:
(2)

Embla Medical hf.: Embla Medical Recognized for Leadership in Accessibility and International Reach

Company honored by Forbes Magazine for Championing Accessibility and by Iceland's President for Excellence in Global Exports

REYKJAVÍK, Iceland, June 18, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, is being internationally recognized for its pioneering role in enhancing peoples' mobility and its business leadership, the company announced today.

Forbes Magazine has named Embla Medical to its first-ever global Accessibility 100 list, recognizing the company's history of innovative prosthetics, neuro orthotics and bracing solutions, and high-quality patient care services. The prestigious list recognizes, for the first time, innovators in the field of accessibility for people with disabilities.

Embla Medical is home to a number of leading mobility brands, including Össur, a leading global provider of prosthetics and bracing and supports solutions; Fior & Gentz, an innovative developer of neuro orthotics; and College Park, creators of custom-built prosthetic solutions for people of all activity levels.

Since its founding in 1971, Embla Medical has secured more than 2,100 patents and numerous award-winning designs and is renowned for advancing the Orthotic & Prosthetic (O&P) industry. The company also operates ForMotion patient care clinics, which provide innovative solutions, expert guidance, and personalized care and support to patients in countries around the globe.

The Forbes list was curated through interviews with more than 400 accessibility leaders across 15+ countries. Organizations were selected based on impact, innovation, and potential to drive systemic change across industries. In addition to Embla Medical, other companies on the list include global tech giants Google, Apple, Microsoft, Meta, and Sony, and apparel brand Nike, with whom Össur partnered for the Nike Sole on its Össur Cheetah® sports blade.

"Accessibility is a fascinating space that has never been captured like this before," said Alan Schwarz, Forbes Assistant Managing Editor who spearheaded the project. "There are lone innovators, juggernaut tech companies, startups. They are revolutionizing how people get around, learn, communicate, work, play sports, travel, and so much more. Their impact on people's lives is monumental - and will only be getting more so soon."

"We are honored to have received this recognition as a purpose-driven company that is passionately committed to improving the quality of life for people experiencing chronic mobility challenges," said Sveinn Sölvason, Embla Medical's President and CEO. "From designing award-winning mobility solutions to operating our network of patient care clinics, we remain singularly focused on providing innovative mobility solutions that help more people live a Life Without Limitations."

According to Sölvason, Embla Medical has also received the President of Iceland's Export Award for 2025, recognizing the company's success as an international business.

"This recognition speaks to the dedication, and global impact of our entire team, and accepting the award from President Halla Tómasdóttir was a very meaningful moment," Sölvason said, noting that the first time the company received this honor was in 1992, as a small Icelandic company employing around 20 people at that time.

"Today," he continued, "we have more than 4,000 employees, operating in 36 countries, and countless individuals rely on our solutions every day. What hasn't changed over the years is our purpose: to improve the lives of people facing mobility challenges. Although we have grown globally, our roots remain in Iceland, shaped by a culture of resilience, innovation, and ambition. This award is not just a celebration of how far we've come - it's also a reminder of the importance of continued investment in new innovation and the conditions that allow global businesses to thrive."

Contact:
Edda H. Geirsdottir
VP of Corporate Communications
egeirsdottir@emblamedical.com

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/embla-medical-hf-/r/embla-medical-recognized-for-leadership-in-accessibility-and-international-reach,c4166021

Cision View original content:https://www.prnewswire.co.uk/news-releases/embla-medical-recognized-for-leadership-in-accessibility-and-international-reach-302485062.html

© 2025 PR Newswire
Epische Goldpreisrallye
Der Goldpreis hat ein neues Rekordhoch überschritten. Die Marke von 3.500 US-Dollar ist gefallen, und selbst 4.000 US-Dollar erscheinen nur noch als Zwischenziel.

Die Rallye wird von mehreren Faktoren gleichzeitig getrieben:
  • · massive Käufe durch Noten- und Zentralbanken
  • · Kapitalflucht in sichere Häfen
  • · hohe Nachfrage nach physisch besicherten Gold-ETFs
  • · geopolitische Unsicherheit und Inflationssorgen

Die Aktienkurse vieler Goldproduzenten und Explorer sind in den vergangenen Wochen regelrecht explodiert.

Doch es gibt noch Titel, die Nachholpotenzial besitzen. In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Goldaktien jetzt besonders aussichtsreich sind und warum der Aufwärtstrend noch lange nicht vorbei sein dürfte.

Laden Sie jetzt den Spezialreport kostenlos herunter und profitieren Sie von der historischen Gold-Hausse.

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.